Identification and characterization of endonuclein binding proteins: evidence of modulatory effects on signal transduction and chaperone activity by Ludvigsen, Maja et al.
BioMed  Central
Page 1 of 11
(page number not for citation purposes)
BMC Biochemistry
Open Access Research article
Identification and characterization of endonuclein binding proteins: 
evidence of modulatory effects on signal transduction and 
chaperone activity
Maja Ludvigsen1, Morten Østergaard1, Henrik Vorum2, Christian Jacobsen1 
and Bent Honoré*1
Address: 1Department of Medical Biochemistry, Aarhus University, Ole Worms Allé 3, Building 1170, Aarhus, DK-8000 Aarhus C, Denmark and 
2Department of Ophthalmology, Aalborg Hospital, Aarhus University Hospital, Hobrovej 10, DK-9000 Aalborg, Denmark
Email: Maja Ludvigsen - maja@biokemi.au.dk; Morten Østergaard - moej@biokemi.au.dk; Henrik Vorum - hv@biokemi.au.dk; 
Christian Jacobsen - cj@biokemi.au.dk; Bent Honoré* - bh@biokemi.au.dk
* Corresponding author    
Abstract
Background: We have previously identified endonuclein as a cell cycle regulated WD-repeat
protein that is up-regulated in adenocarcinoma of the pancreas. Now, we aim to investigate its
biomedical functions.
Results: Using the cDNA encoding human endonuclein, we have expressed and purified the
recombinant protein from Escherichia coli using metal affinity chromatography. The recombinant
protein was immobilized to a column and by affinity chromatography several interacting proteins
were purified from several litres of placenta tissue extract. After chromatography the eluted
proteins were further separated by two-dimensional gel electrophoresis and identified by tandem
mass spectrometry. The interacting proteins were identified as; Tax interaction protein 1 (TIP-1),
Aα fibrinogen transcription factor (P16/SSBP1), immunoglobulin heavy chain binding protein (BiP),
human ER-associated DNAJ (HEDJ/DNAJB11), endonuclein interaction protein 8 (EIP-8), and
pregnancy specific β-1 glycoproteins (PSGs). Surface plasmon resonance analysis and confocal
fluorescence microscopy were used to further characterize the interactions.
Conclusions: Our results demonstrate that endonuclein interacts with several proteins indicating
a broad function including signal transduction and chaperone activity.
Background
Pancreatic cancer is the seventh most common cause of
cancer death in Western society with a 5-year survival rate
of approximately 5.5% being the lowest 5-year relative
survival rate of all cancers. The incidence rate of this
aggressive tumor is increasing and the treatment is ineffec-
tive with a poor prognosis [1,2]. Recently, gathering of
data concerning genomics and proteomics studies of pan-
creatic cancer showed differential regulation of 2,516
potential biomarkers [3]. These include known oncogenes
and cell cycle regulators, e.g., the ras oncogene [4], p53
[5], SMAD4 [6], epidermal growth factor and epidermal
growth factor receptor [7], cyclin D1 [8], CDK4I [9], as
well as insulin-like growth factor-1 receptor, stat-3 and the
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tyrosine kinase src [10]. Still, the molecular biology of the
disease is not well understood and a more thorough inves-
tigation of the specific proteins is crucial
In an earlier study, we have revealed that endonuclein
[11], a cell cycle regulated WD-repeat protein, also con-
tributes to the development of the protein phenotype of
pancreatic cancer. WD-repeat proteins usually consist of
4-16 WD-repeats forming an up to eight blade propeller
structure creating a stable platform that may form com-
plexes reversibly with several proteins [12]. Despite of the
structural similarity between these members they are a
functionally diversified group where all members seem to
possess regulatory functions e.g. proteins including cell
division control proteins, coatomer b subunits, transcrip-
tion initiation factors, microtube associate proteins, actin
interacting proteins, as well as enzymes like protein phos-
phatase 2A and myosin heavy chain kinase A 3-13 [13-
23]. To date, the function of the various protein members
have thus been ascribed to crucial regulatory roles in sig-
nal transduction, RNA processing, gene expression, traf-
ficking of vesicles, assembly of cytoskeletal components
as well as participation in the regulation of the cell cycle
[24].
Since several WD-repeat proteins are known to form mul-
tiprotein complexes by interacting with other proteins
sometimes through their WD-repeat domains, we set for-
ward studies to reveal which function(s) that may be
attached to endonuclein by identifying interacting pro-
teins. Consequently, we have expressed recombinant
endonuclein in Escherichia coli and used the purified
immobilized protein to affinity purify several endonu-
clein interacting proteins from a placental tissue extract. A
proteomic approach using two-dimensional gel electro-
phoresis (2D-PAGE) and tandem mass sepctrometry (MS/
MS) [25] together with a number of proteins assays were
used to further characterize the proteins. The nature of the
affinity purified proteins confirms that endonuclein may
possess regulatory functions. Thus, among the interacting
proteins, we have identified, are TIP-1 (a PDZ protein that
interacts with the oncogenic HTLV-1 Tax protein), mt-SSB
(a transcription factor) and a number of stress related pro-
teins belonging to the molecular chaperones. Thus, we
have discovered and characterized a number of putative
functions of endonuclein that will be discussed in light of
the disclosure of the interacting partners.
Results
In order to detect endonuclein interacting proteins, we
immobilized recombinant endonuclein to a column and
prepared a reference column without immobilized endo-
nuclein. Similar volumes of placental tissue extract were
added to both columns at neutral pH. After a wash of both
columns with 1 M NaCl, proteins that interacted with the
immobilized endonuclein were eluted with 0.1 M glycine
buffer (pH 2.7) and subsequently neutralized with 1 M
Tris-HCl, pH 9. Both eluates from the endonuclein col-
umn and the reference column were concentrated and
subjected to 2D-PAGE as shown in Fig 1. Several proteins
were found to interact specifically with endonuclein as
indicated with numbers in Fig 1A. A few proteins inter-
acted non-specifically with the column matrix as given
with arrowheads in Fig 1B. Of several proteins that were
subjected to partial internal sequencing by MS/MS, eight
spots could be unambiguously identified as given in Table
1. The localization of the identified interacting proteins is
in line with the previously established nuclear localiza-
tion and cytoplasmic localization in the endoplasmic
reticulum of endonuclein by immunoelectron and confo-
Affinity purification of endonuclein interacting proteins Figure 1
Affinity purification of endonuclein interacting pro-
teins. A placental tissue extract was applied to a column 
with immobilized endonuclein, (A), and to a parallel column 
without endonuclein, (B), in a physiologic buffer. Proteins 
were eluted from both columns at pH 2.7. The eluates were 
neutralized and finally subjected to two-dimensional gel elec-
trophoresis with subsequent silver staining. Arrows with 
numbers indicate protein spots that were excised from the 
gel and subjected to nano-electrospray tandem mass spec-
trometry for identification. The partial sequences and the 
names of the identified proteins are shown in Table 1. Pro-
teins that interacted unspecifically with the column matrix 
are given with arrowheads.BMC Biochemistry 2009, 10:34 http://www.biomedcentral.com/1471-2091/10/34
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cal laser scanning microscopy [11]. Each of the proteins
will be described in detail below.
Identification of protein spots No. 1 and No. 16
Protein spot No. 1 gave the peptide sequence ELEEIVQPI-
ISK which was identified as a peptide located in the C-ter-
minal of immunoglobulin heavy chain binding protein
BiP or Grp78 [26]. Similarly, protein No. 16 gave 5 pep-
tides (Table 1) that also were found in BiP. Peptide spots
No. 1 and 16 with molecular masses around 25-30 kDa
thus represent C-terminal cleavage products of BiP that
has a molecular mass around 72 kDa. In order to verify
the interaction with BiP, we performed surface plasmon
resonance experiments by flowing hamster BiP that pos-
sesses more than 98% sequence identity to human BiP
over the immobilized endonuclein. As seen from Fig 2
these experiments verified that there was an interaction
between the immobilized endonuclein and BiP. As a con-
trol recombinant GST revealed no detectable binding.
Identification of protein spots No. 2 and No. 11
Both spot No. 2 and No. 11 gave the sequence VSEGG-
PAEIAGLQIGDK that identified the protein as Tax interac-
tion protein 1, TIP-1 [27,28]. The localization of protein
spots No. 2 and No. 11 in the 2D gel is in agreement with
the deduced molecular mass of 12.9 kDa and pI of 9.2 for
TIP-1. The surface plasmon resonance experiments shown
in Fig 2 were used to verify that recombinant TIP-1 protein
constructed as fusion protein with GST interacted with
endonuclein. Separate control experiments revealed that
pure GST protein did not interact with endonuclein. To
establish evidence that endonuclein and TIP-1 are local-
ized to the same subcellular compartment, we performed
double immunocytochemistry on cultured HaCat cells. As
shown in Fig 3 the two proteins co-localize in the cyto-
plasm (Fig 3A) and to some extend in the nucleus (Fig
3B).
Identification of protein spot No. 4
Protein spot No. 4 revealed the peptide sequence TLEV-
EIEPGVR that identified the protein as DnaJ homolog
subfamily B member 11, DNAJB11 [29]. The molecular
mass of the predicted protein is calculated to be 40.5 kDa
and the pI to 5.8, i.e. very close to the experimental values
observed, see Fig 1. By using the publicly available WWW
server that is based on neuronal networks [30,31], the N-
Table 1: Identification of endonuclein interacting proteins by peptide sequencing using tandem mass spectrometry.
Protein spot No. Peptide sequence obtained by tandem 
mass spectrometry
Identification of protein Localization Mr (kDa) pI
1 ELEEIVQPIISK BiP/Grp78 ER resident 72.1 4.9
2 VSEGGPAEIAGLQIGDK TIP-1 Cytoplasm*
Nucleus
12.9 9.2
4 TLEVEIEPGVR DNAJB11/HEDJ (EIP-4) ER/secreted 40.5 5.8
8 TGAELVTCGSVLK SDF2-like protein 1 (EIP-8) ER resident 23.6 6.6
10 Failed
11 VSEGGPAEIAGLQIGDK TIP-1 Cytoplasm*
Nucleus
12.9 9.2
16 SQIFSTASDNQPTVTIK
TFDLTGI
LTPEEIER
NELESYAYSLK
KKELEEIVQPIISK
BiP/Grp78 ER resident 72.1 4.9
17 SGDSEVYQLGDVSQK
VGQDPVLR
Mt-SSB (ssDNA binding protein/P16) Mitochondria
Nucleus*
Cytoplasm
17.2 10.5
18 ENKDVLTFTCEPK
ILILPSVTR
LSIPQITTK
LFIPQITTK
Pregnancy specific β-1 glycoproteins
(PSBGs)
ER/secreted 36.2-52.7 8.0-9.3
*Determined by laser scanning confocal microscopy in present workBMC Biochemistry 2009, 10:34 http://www.biomedcentral.com/1471-2091/10/34
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terminal 22 amino acids were found to have the hydro-
phobic characteristics of a signal peptide for directing the
protein into the ER with a likely cleavage site between Ala-
22 and Gly-23 which is consistent with the protein locali-
zation in strong association with the ER membrane ori-
ented towards the ER lumen [29]. The protein also
exhibits a J domain after the signal sequence. The J
domain is a highly conserved domain of about 70 amino
acids found in the hsp40 protein family that consist of
over 100 members [32]. Further towards the C-terminal
there is an RGD motif which may serve a role in cell adhe-
sion, since this sequence can bind to the integrins [33].
The different domains of DNAJB11 are shown in Fig 4A.
Identification of protein spot No. 8
Protein spot No. 8 gave the sequence TGAELVTCGSVLK
that identified the protein as stromal cell-derived factor 2-
like protein 1, SDF2-like protein 1 [34]. By analyzing the
sequence using the WWW server [30,31], we found a puta-
tive signal sequence with an indicated cleavage site
between Ala-28 and Ala-29. Furthermore, the protein ter-
minates with the HDEL signal which has been identified
as an ER retrieval signal in some of the CREC proteins [35-
37] suggesting that the protein is localized as a resident
protein within the ER. The database search showed that
the protein possesses a strong similarity to the stromal cell
derived factor-2, SDF-2 [38] which has been reported to
contain MIR domains, since these are also found in pro-
tein  O-mannosyl-transferases, inositol 1,4,5-trisphos-
phate receptors and ryanodine receptors [39]. The three
MIR domains present in SDF2-like protein 1 are shown in
Fig 4B.
Identification of protein spot No. 17
From spot No. 17, we obtained two peptide sequences;
SGDSEVYQLGDVSQK and VGQDPVLR. Both peptides
showed a perfect identity match to the mitochondrial sin-
gle-stranded DNA binding protein, mt-SSB [40]. To fur-
ther investigate this interaction, we performed double
immunocytochemistry on cultured HaCat cells (Fig 3). In
most cells, endonuclein and mt-SSB did not co-localize to
the same cellular compartment (Fig 3C). However, few
cells showed a clear presence of mt-SSB in the nucleus co-
localizing with endonuclein (Fig 3D). This is consistent
with the fact, that this protein has been reported to be
mainly localized in the mitochondria, while small
amounts have been detected within the nucleus and in the
Surface plasmon resonance analysis of the binding of proteins  to endonuclein Figure 2
Surface plasmon resonance analysis of the binding of 
proteins to endonuclein. Endonuclein was immobilized to 
a sensor chip and the on and off rates for ligand binding were 
recorded on a BIAcore 2000. The recorded sensorgrams 
show binding of 1 μM of pregnancy specific β-1 glycoprotein, 
5 μM recombinant TIP-1 as fusion peptide with glutathion S-
transferase (GST-TIP-1), 1 μM BiP and 1 μM of pure glutath-
ion S-transferase (GST) as a control. Interaction with endo-
nuclein was verified with all proteins except GST which 
revealed no detectable binding.
Immunocytochemistry stainings of HaCat keratinocytes Figure 3
Immunocytochemistry stainings of HaCat keratinoc-
ytes. (A) Double staining of endonuclein and TIP-1 showing 
co-localization in the cytoplasm (x40) and (B) in the nucleus 
(x100). (C) Double staining of endonuclein and mt-SSB 
showing no co-localization (x40) and (D) co-localization in 
the nucleus (x63).BMC Biochemistry 2009, 10:34 http://www.biomedcentral.com/1471-2091/10/34
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cytoplasm [41]. In addition, it has been shown that mt-
SSB is a transcription factor for the Aα fibrinogen gene
[42]. The mt-SSB gene has been assigned to chromosome
7 at 7q34 [43], spanning about 12 kb.
Identification of protein spot No. 18
Spot No. 18 revealed the peptides ENKDVLTFTCEPK, ILI-
LPSVTR, LSIPQITTK and LFIPQITTK. By searching the
databases, we found that these peptides corresponded to
the pregnancy specific β-1 glycoprotein 1 (PSBG-1)
branch of the carcinoembryonic antigen family, where to
date 11 proteins have been identified, PSBG1 - PSBG11
[44]. The PSGs are abundantly expressed in placenta dur-
ing embryonic development and also in uterus, pancreas,
testis and fetal liver. The PSGs contain signal sequences
and are secreted proteins [44]. Many of them contain an
RGD sequence which may serve a role in cell adhesion,
since this sequence may bind to the integrins [33]. The
peptides identified (Table 1) may correspond to several of
the PSBGs. Surface plasmon resonance experiments with
a commercial preparation of PSBG indeed verified that
endonuclein may interact with members of this class of
proteins (Fig 2).
Ca2+-binding to endonuclein
Binding of Ca2+ to endonuclein was measured with the
protein in solution using the rate dialysis technique [45].
A Scatchard plot of the data is shown in Fig 5. The data
obtained may be interpreted by a model where endonu-
clein contains two Ca2+-binding sites, each binding Ca2+
with a dissociation constant, kD, of 240 μM at physiologic
conditions.
Discussion
Endonuclein, previously known as IEF SSP 9502 [46] and
the yeast homologue PWP1, are WD-repeat proteins that
to date have been described in a very limited number of
papers [11,46-51]. In previous studies endonuclein has
been reported to be up-regulated at the transcript level
[47] as well as at the protein level [11] in adenocarcinoma
of the pancreas. Up-regulation of this protein in cancer
may be in line with the fact that endonuclein is identified
as a cell cycle regulated protein synthesized at increasing
levels and with nuclear focusing during interphase [11].
Up-regulation of the protein may promote the cell cycle in
line with the observation that yeast cells with a null muta-
tion of the homologous gene (PWP1) grow slowly [50].
PWP1 is involved in ribosome biosynthesis through its
interaction with trans-acting ribosome biogenesis factors
and with several ribosome protein subunits [51]. In addi-
tion, it has recently been shown that PWP1 associates with
the 25S ribosomal DNA chromatin (rDNA), and that
PWP1 may play a role in regulation of rDNA transcription
Structure of two endonuclein interacting proteins Figure 4
Structure of two endonuclein interacting proteins. (A) Endonuclein interacting protein 4, DNAJB11, contains a signal 
sequence that is putatively cleaved off between Ala-22 and Gly-23. It contains a DnaJ domain (green box) and an RGD 
sequence (yellow box) and might be secreted due to the lack of an ER retrieval sequence. (B) SDF2-like protein 1 contains a 
signal sequence that is putatively cleaved off between Ala-28 and Ala-29. It contains three MIR domains (blue box) and a HDEL 
ER retrieval sequence (purple box).
Ca2+-binding to endonuclein Figure 5
Ca2+-binding to endonuclein. Binding of Ca2+ was meas-
ured in 150 mM KCl, 50 mM Hepes, pH 7.4 at 37°C with the 
rate dialysis procedure [45]. The data were fitted to the 
Scatchard equation and the analysis was in agreement with a 
model consisting of two independent sites (n = 1.94) each 
with the dissociation constant kD = 238 μM.BMC Biochemistry 2009, 10:34 http://www.biomedcentral.com/1471-2091/10/34
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[48]. Furthermore, the recent finding that endonuclein is
downregulated during heat stress-induced apoptosis [49],
suggests that indeed this protein is involved in diverse
important cellular functions. Since WD-repeat proteins as
a rule possess regulatory functions rather than enzymatic
[24], we further explored the functional roles of endonu-
clein by biochemical analyses with emphasis on the iden-
tification and characterization of its interacting proteins.
Endonuclein interacting proteins (Table 1) may largely be
classified into two groups, one that is involved in signal
transduction from the cytosol to the nucleus and another
that participates in chaperone activities in the ER. These
localizations are in line with the previous observation by
immunoelectron and laser scanning fluorescence micros-
copy [11] that endonuclein localizes to the nucleus as well
as to the cytoplasm in the endoplasmic reticulum indicat-
ing that the interactions observed may be of functional
significance. The results are summarized in Fig 6. In the
cytosol endonuclein may interact with the Tax interaction
protein 1, TIP-1. TIP-1 was originally identified as a PDZ
domain protein interacting with the C-terminal of Tax, a
40 kDa nuclear phosphoprotein encoded by HTLV-1 [27],
and recent studies have identified TIP-1 as an atypical
PDZ protein that functions as a negative regulator of PDZ-
based scaffolding [52]. Tax is considered to be oncogenic
by trans-activating a number of viral and cellular genes
[53], and it has been shown that overexpression of TIP-1
reduced the proliferation and growth of colorectal cancer
cells [54]. Since Tax is not a DNA binding protein per se, it
Model of endonuclein functions Figure 6
Model of endonuclein functions. Endonuclein may modulate several signal transduction pathways to the nucleus as well as 
chaperone activities in the ER. Through interaction with TIP-1, endonuclein may interfere with the Rho signaling pathway and 
the pathway leading to oncogenesis by Tax. RhoA, rhotekin and TIP-1 may form a ternary complex in the cytosol (indicated 
with two-way green arrows) that produces a signal in the nucleus increasing c-fos transcription (indicated with one-way green 
arrows). Tax may trans-activate a number of genes, e.g. c-fos (red arrows) through interaction with a number of cellular pro-
teins. IL-6 stimulation activates two signaling pathways one involving the Janus kinases (Jaks) and one involving the MAP kinase 
cascade. The Jaks phosphorylate stat-3, which is then translocated into the nucleus. Usually, stat-3 then binds to the IL-6 
response element (IL-6 RE), however, this does not occur at the Aα fibrinogen promoter that instead binds the transcription 
factor P16 (mt-SSB). The IL-6 induced transcription of Aα fibrinogen may thus be modulated by interaction of endonuclein 
with P16. In the ER endonuclein may modulate chaperone activities by interacting with the membrane bound co-chaperone 
HEJD (DNAJB11) and the chaperone BiP. The significance of the interaction of endonuclein with EIP-8 (SDF2-like protein 1) 
and PSGs (PSBGs) in the ER is unknown at present. Two-way arrows indicate putative protein-protein interactions. Protein 
motifs or domains are indicated on the proteins, MIR, RGD, PDB, J, PDZ, SSB and NLS.BMC Biochemistry 2009, 10:34 http://www.biomedcentral.com/1471-2091/10/34
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executes its action through the binding of other cellular
proteins. However, which specific trans-activation path-
way that is essential for transformation of cells still
remains controversial [53]. Interestingly, TIP-1 that con-
tains a PDZ domain has been reported to interact with the
C-terminal of rhotekin [28]. Rhotekin was identified as a
target protein of the Rho family of small GTPases [55]. A
ternary complex of active Rho with rhotekin and TIP-1
produces a signal in the cytosol that triggers strong activa-
tion of the c-fos serum response element [28] that also is
activated by Tax [53]. How the signal from the ternary
complex in the cytosol is transferred to the nucleus is
unknown. The interaction of endonuclein with TIP-1
could thus have modulatory actions on the Rho signal
transduction pathway as well as on the pathway that leads
to oncogenesis induced by Tax. Such a modulatory effect
on signal transduction pathways is further substantiated
by the observation that endonuclein may interact with
mt-SSB, a transcription factor for the Aα fibrinogen gene
[42]. This gene is induced by interleukin-6 (IL-6) which
activates two signal transduction pathways; the Janus
kinases that phosphorylate a group of latent cytoplasmic
transcription factors known as stats and the MAP kinase
signaling cascade that activates the C/EBP transcription
factors. Upon phosphorylation, stat-3 is translocated to
the nucleus and generally binds to the IL-6 response ele-
ment (IL-6 RE) of the genes that it activates. However, stat-
3 does not associate with the IL-6 RE of the fibrinogen
promoter. Instead mt-SSB is attached to this site. Upon IL-
6 stimulation mt-SSB transiently leaves the site and re-
associates again later. The further details of the molecular
mechanism whereby IL-6 trans-activates the Aα fibrinogen
gene remains to be investigated [56,57]. Endonuclein may
thus putatively modulate the signal transduction pathway
through its interaction with mt-SSB.
In the ER, endonuclein may interact with proteins of the
molecular chaperones that assist in the folding of proteins
[32]. The specific endonuclein interacting proteins identi-
fied was BiP that is involved in protein translocation, fold-
ing, refolding and degradation of proteins in the ER as
well as reverse translocation of proteins from the ER to the
cytosol for ubiquitination and degradation in the protea-
some [26,58]. In presence of ATP, BiP interacts with the J
domain of DNAJB11 and may activate the ATPase activity
of BiP during its action [29]. Both BiP and DNAJB11 have
recently been implied as target genes in the mammalian
unfolded protein response (UPR) [59,60]. Endonuclein
may thus through its interaction with DNAJB11 and BiP
modulate the chaperone activity in the ER.
Finally, two other proteins of the ER were observed to
interact with endonuclein. PSBGs which are a group of
secretory proteins that are abundantly expressed in the
placenta during embryonic development and which may
have immunomodulatory functions [44] and SDF2-like
protein 1 which is a novel protein that contains three MIR
domains. The latter motifs are found in three classes of
proteins in the ER [39], protein O-mannosyl-transferases,
which catalyzes transfer of mannose from dolichyl acti-
vated mannose to seryl or threonyl residues of secretory
proteins [61] and two classes of intracellular Ca2+-release
channel proteins, the ryanodine receptors and the inositol
1,4,5-trisphosphate receptors [62]. From these proteins, it
is known that the MIR domains in the protein O-manno-
syl-transferases are essential for its enzymatic function
[63] whereas they are involved in binding of inositol
1,4,5-trisphosphate in the signal transduction pathway
that releases Ca2+ from intracellular stores. In this respect,
it may be of importance that endonuclein can bind two
Ca2+ ions, each with a kD of approximately 240 μM. Endo-
nuclein thereby possesses the ability of binding Ca2+ with
the concentrations of free Ca2+ that are present in the ER
ranging from about 400 μM in resting cells to below 50
μM after Ca2+-mobilization [64]. It is thus possible that
the physiologic effect of endonuclein in the ER is Ca2+
dependent. However, the specific functions of the MIR
domains in SDF2-like protein 1 must await further stud-
ies, although it may be anticipated that the domains pre-
sumably are involved in the binding to endonuclein since
SDF2-like protein 1 almost exclusively consists of three
MIR domains (Fig 4B).
Conclusions
In conclusion, we have found that the nature of the endo-
nuclein interacting proteins confirms a regulatory role for
endonuclein, especially with respect to modulation of sig-
nal transduction pathways to the nucleus and chaperone
activities in the ER. The specific function(s) of endonu-
clein in these processes will be the focus of future studies.
Methods
Expression of recombinant proteins in Escherichia coli
The coding region (Asn2-Ser501) of the 2309.2-cDNA [46]
was PCR amplified essentially as previously described
[65]. The primer used in the sense direction contained a
BamHI site (9502F): 5'-CAC-GGA-TCC-ATC-GAG-GGT-
AGG-AAC-CGC-AGC-CGC-CAG-G-3' and the primer
used in the antisense direction contained a HindIII site 5'-
TTC-AAG-CTT-AAG-ACT-CCA-TGG-GTG-TAT-3'. The
PCR-amplified DNA-fragment was cut with the appropri-
ate enzymes and finally ligated into the expression vector
pT7-PL giving a fusion protein that was synthesized with
MGSHHHHHHGSIEGR in the NH2-terminal (pT7-PL-
2309.2). I.M.A.G.E. Consortium (LLNL) cDNA Clone IDs
743176, 725923 and 704842 in pT7T3D-Pac and
2178588 in pCMV-SPORT6 [66] were obtained from the
American Type Culture Collection (Maryland). The clones
were sequenced with primer walking directly on the dou-
ble stranded plasmids with the dideoxynucleotide chainBMC Biochemistry 2009, 10:34 http://www.biomedcentral.com/1471-2091/10/34
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termination technique [67] using deoxyadenosine 5'[α-
35S]thiotriphosphate or using the service facility at MWG
Biotech AG (Ebersberg, Germany). The sequences of the
clones were submitted to the databases under the Gen-
Bank accession Nos. GenBank:AF277316, Gen-
Bank:AF277317, GenBank:AF277318 and
GenBank:AF277319 for the I.M.A.G.E. clone IDs:
2178588 (SDF2-like protein 1/EIP-8), 704842
(DNAJB11/EIP-4), 725923 (TIP-1) and 743176 (mt-SSB).
Open reading frames (ORFs) were sequenced on both
strands. Outside ORFs we performed mainly one strand
sequencing. The coding regions of the TIP-1 cDNA was
PCR amplified with specific primers containing specific
restriction sites, TIP-1, F: CGT-GGA-TCC-ATG-TCC-TAC-
ATC-CCG-GGC-CA; TIP-1, R: TCG-GAA-TTC-TAG-GAC-
AGC-ATG-GAC-TG. The PCR fragment was purified by gel
electrophoresis cut with enzymes and ligated into the pro-
tein expression plasmid pGEX-4T3 so that the coding
region of the protein was made as a fusion protein with
glutathion-S transferase, GST according to the manufac-
turer (GE Healthcare). After subcloning, the plasmid was
sequenced to insure that no PCR errors were introduced.
Sequence identity search was carried out in the publicly
available DNA and protein databases at the National
Center for Biotechnology Information, NCBI, using the
basic local alignment search tool, BLAST [68]. Sequence
analyses were performed with the Gene Inspector™ and
the Gene Construction Kit 2™ programs (Textco, Inc, West
Lebanon, New Hampshire). The recombinant plasmids
were propagated in E. coli XL-1 Blue, DH5α or DH10B
and sequenced in order to check the cDNA insert for errors
introduced during the amplification process. The proteins
were expressed and purified from E. coli cells essentially as
previously described in detail with the pT7-PL vector [69]
and according to the manufacturer with pGEX (GE
Healthcare). As a control, pure GST protein was purified
from cells transformed with the pGEX-4T3 vector contain-
ing no insert.
Affinity purification of endonuclein interacting proteins
Recombinant endonuclein was coupled to cyanogen bro-
mide-activated Sepharose 4B according to the manufac-
turers description (Pharmacia, Sweden) and packed as a
column. A reference column without recombinant endo-
nuclein coupled was similarly packed. A tissue extract
from placenta was made as previously described [70].
Identical amounts (several liters) were applied to both
columns in MB-buffer (2 mM CaCl2, 1 mM MgCl2, 140
mM NaCl, 10 mM Hepes, pH 7.4). After washing of the
columns in MB-buffer with 1 M NaCl interacting proteins
were eluted with 0.1 M glycine buffer (pH 2.7) and neu-
tralized with 1 M Tris-HCl, pH 9. The eluate was concen-
trated and subjected to two-dimensional gel
electrophoresis.
Two-dimensional gel electrophoresis (2D-PAGE) and silver 
staining
Two-dimensional gels were run in the first dimension
with IPG strips 3-10NL from GE Healthcare. The second
dimension was performed on home made polyacryla-
mide gels (15%T, 0.5%C). Subsequently the gels were sil-
ver stained as previously described [71]. After running
gels, they were fixed in 50% (v/v) methanol, 12% (v/v)
acetic acid, 0.0185% (v/v) formaldehyde overnight or at
least for 1 hr, then washed 3 times for 20 min in 35% (v/
v) ethanol and pretreated for 1 min in pretreatment solu-
tion: 0.02% (w/v) Na2S2O3,5H2O, then rinsed in water 2
times for 3 min, stained in 0.2% (w/v) AgNO3, 0.028%
(v/v) formaldehyde for 20 min, rinsed with water 2 times
for 20 s and developed in development solution: 6% (w/
v) Na2CO3, 0.0185% (v/v) formaldehyde, 0.0004% (w/
v) Na2S2O3,5H2O, for approximately 3 min. Finally,
development was stopped in stop solution; 50% (v/v)
methanol, 12% (v/v) acetic acid.
Mass spectrometry identification of endonuclein 
interacting proteins
Silver stained protein spots from gels were excised and
kept in 5% (v/v) acetic acid until digestion which was per-
formed at Protana A/S (Odense, Denmark) in a 96-well
plate using the protocol essentially as described [72].
Briefly, the gel spots were washed with 50 mM
NH4HCO3/acetonitrile (1:1) followed by dehydration
with acetonitrile. The proteins were reduced in 10 mM
dithiotreitol (DTT)/50 mM NH4HCO3 for 1 hour at 56°C,
and alkylated in 55 mM iodoacetamide/50 mM
NH4HCO3 at room temp. The gel pieces were washed sev-
eral times in 50 mM NH4HCO3 followed by dehydration
with acetonitrile. The proteins were digested overnight
with trypsin (Promega, modified trypsin) at 37°C and the
resulting peptide mixtures were purified on POROS R2
perfusion chromatography material in purification capil-
laries. The peptide mixtures were eluted with 50% (v/v)
methanol, 5% (v/v) formic acid into the nanospray capil-
lary by centrifugation. Peptide sequencing by tandem
mass spectrometry (MS/MS) was performed using a nano-
electrospray system coupled to a prototype QqTOF
(QSTAR) mass spectrometer (Sciex, Toronto, Canada).
Each peptide mass and the partial amino acid sequence
were arranged in peptide sequence tags [72] and used to
search the nrdb database. All the software used for data-
base queries and management of all mass spectrometric
data and search results were developed at Protana A/S
(Odense, Denmark).
Analyses of protein interactions by surface plasmon 
resonance
Protein-protein interactions were studied essentially as
previously described [70] in 10 mM Hepes, 150 mM
NaCl, 5 mM CaCl2, 1 mM EGTA, pH 7.4, 0.005% P20. InBMC Biochemistry 2009, 10:34 http://www.biomedcentral.com/1471-2091/10/34
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short, surface plasmon resonance measurements were
performed on a BIAcore 2000 instrument (Biacore, Upp-
sala, Sweden). This technology relies on the phenomenon
of the surface plasmon resonance that occurs when sur-
face plasmon waves are excited at a metal/liquid interface.
Light is directed at, and reflected from, the side of the sur-
face not in contact with sample, and surface plasmon res-
onance causes a reduction in the reflected light intensity at
a specific combination of angle and wavelength. Biomo-
lecular binding events cause changes in the refractive
index at the surface layer, which are detected as changes in
the surface plasmon resonance signal. In general, the
refractive index change is proportional to change in mass
concentration at the surface layer.
Coupling of endonuclein was performed by using the
amine coupling method. Briefly, a continuous flow of
HBS buffer (10 mM HEPES pH 7.4, 3.4 mM EDTA, 150
mM NaCl, 0.005% surfactant P20) passing over the sensor
surface of a CM5 sensor chip was maintained at 5 μl/min.
The carboxylated dextran matrix of the sensor chip flow
cell 1 and 2 was activated by the injection of 60 μl of a
solution containing 0.2 M N-ethyl-N'-(3-dimethylamino-
propyl)carbodiimide and 0.05 M N-hydroxysuccimide in
water. Endonuclein was then at a concentration of 50 μg/
ml in 10 mM sodium acetate pH 4.0 injected over flow
cell 2 with a flow rate of 5 μl/min. Totally 60 μl was
injected. The remaining binding sites in both flow cells
were blocked by injection of 35 μl 1 M ethanolamine pH
8.5. The surface plasmon resonance signal from immobi-
lized endonuclein generated 3302 BIAcore response units
(RU) equivalent to 59 fmol endonuclein/mm2. Pregnancy
specific β-1 glycoprotein was from Advanced Immuno-
chemical, Inc. (CA). Recombinant hamster BiP/Grp78
was from Calbiochem. TIP-1 was made as GST fusion pro-
tein as described above. Proteins were dissolved in 10 mM
Hepes, 150 mM NaCl, 5 mM CaCl2, 1 mM EGTA, pH 7.4,
0.005% P20 at concentrations of 1 μM or 5 μM and ana-
lyzed by injecting 40 μl onto the derivatized sensor chip
and the control flow channel. The BIAcore response is
expressed in relative response units (RU), i.e., the differ-
ence in response between flow cell with immobilized
endonuclein and the control flow channel. Injecting two
times 20 μl 1.6 M glycine-HCl buffer, pH 3.0 performed
regeneration of the sensor chip after each analysis cycle.
Immunocytochemistry
HaCat keratinocyte cells were grown on coverslips in
DMEM supplemented with 10% (vol/vol) fetal bovine
serum and antibiotics (penicillin at 100 units/ml and
streptomycin at 50 μg/ml). Coverslips were washed in PBS
(10 mM phosphate, 150 mM NaCl, pH 7.3), fixed in PBS
supplemented with 4% paraformaldehyde, and finally
washed in PBS containing 0.1% Triton X-100. The cover-
slips were incubated with primary antibodies for 45 min,
washed in PBS and then incubated with secondary anti-
bodies for 45 min. The primary antibodies were affinity
purified rabbit polyclonal anti-endonuclein (previously
described in [11]), affinity purified goat polyclonal anti-
TIP-1 (Bethyl Laboratories, USA) and affinity purified
chicken polyclonal anti-mt-SSB (P16) (Abcam, UK). The
secondary antibodies were conjugated with Alexa 488 or
Alexa 556, all purchased from Molecular Probes (Invitro-
gen, Denmark). Labelling was analyzed by confocal laser
scanning microscopy (LSM510, Carl Zeiss, Germany). The
high specificity of the endonuclein antibody has previ-
ously been demonstrated by western immunoblotting
[11]. The specificity of the TIP-1 and mt-SSB (p16) anti-
bodies were assessed by ousting the antibodies with the
corresponding recombinant protein. In both cases the
ousting was complete (not shown).
Rate dialysis
Ca2+ binding to endonuclein was measured with the pro-
tein in solution using rate dialysis with the microchamber
procedure essentially as previously described [45]. The
experiments were performed in 150 mM KCl, 50 mM
Hepes, pH 7.4 at 37°C. Buffers and endonuclein solutions
were passed through a Chelex 100 column (BioRad) in
order to remove cations before use. Corresponding sets of
free Ca2+  concentrations, [Ca2+]free, and the average
number of Ca2+ ions bound to endonuclein, r, were meas-
ured and fitted to the Scatchard equation by linear regres-
sion:
where kD is the dissociation constant and n is the number
of binding sites.
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